A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Giant Cell Arteritis [clinicaltrials:NCT00076726]
A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Giant Cell Arteritis [clinicaltrials:NCT00076726]
Bio2RDF identifier
NCT00076726
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00076726
identifiers.org URI
actual enrollment [clinicaltrials_vocabulary:actual-enrollment]
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
The purpose of this stu ...... help reduce painful disease.
brief title [clinicaltrials_vocabulary:brief-title]
A Study of the Safety and Effe ...... ents With Giant Cell Arteritis
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
collaborator [clinicaltrials_vocabulary:collaborator]
completion date [clinicaltrials_vocabulary:completion-date]
2005-07-01T00:00:00Z
condition [clinicaltrials_vocabulary:condition]
condition browse [clinicaltrials_vocabulary:condition-browse]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
country [clinicaltrials_vocabulary:country]
detailed description [clinicaltrials_vocabulary:detailed-description]
The purpose of this stu ...... 2, 6, 14, 22, 30, 38, and 46.
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
2004-02-02T00:00:00Z
intervention [clinicaltrials_vocabulary:intervention]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
keyword [clinicaltrials_vocabulary:keyword]
Giant Cell Arteritis
infliximab
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2011-05-16T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
link [clinicaltrials_vocabulary:link]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00076726
official title [clinicaltrials_vocabulary:official-title]
A Randomized, Double-Masked, P ...... ects With Giant Cell Arteritis
org study id [clinicaltrials_vocabulary:org-study-id]
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
phase [clinicaltrials_vocabulary:phase]
source [clinicaltrials_vocabulary:source]
start date [clinicaltrials_vocabulary:start-date]
2003-11-01T00:00:00Z
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2010-04-01T00:00:00Z
why stopped [clinicaltrials_vocabulary:why-stopped]
Interim analysis, infliximab d ...... glucocorticosteroid dosage
identifier
clinicaltrials:NCT00076726
title
A Study of the Safety and Effe ...... ents With Giant Cell Arteritis
@en
type
label
A Study of the Safety and Effe ...... s [clinicaltrials:NCT00076726]
@en